Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 351 of 6351
-
Can a drug combo tame diabetic nerve pain with fewer side effects?
Symptom relief Not yet recruitingThis study will evaluate the efficacy and safety of low-dose duloxetine combined with alpha-lipoic acid compared with standard-dose duloxetine in adults with painful diabetic peripheral neuropathy. In this assessor-blinded, randomized, parallel-arm, non-inferiority trial, partici…
Sponsor: Bangladesh Medical University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Recruiting nowTQB6426 is a glypican-3 (GPC3)-targeted antibody-drug conjugate (ADC) independently developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Preclinical studies have demonstrated its potent anti-tumor activity coupled with a favorable therapeutic safety window, which provide…
Phase 1 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Long-Term watch program unlock the secrets of genetic prion disease?
Knowledge-focused Recruiting nowPROSPECT is a prospective observational registry and longitudinal natural history study of adults at risk for genetic prion disease.
Sponsor: Brian Appleby • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a pill tame diabetes and obesity together?
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled Phase 1b clinical study designed to evaluate the safety, tolerability, pharmacokinetic profiles and preliminary efficacy of multiple oral doses of TQF3250 capsules in trial subjects with type 2 diabetes mellitus …
Phase 1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can neck exercises turn down the volume on chronic migraine?
Symptom relief Not yet recruitingTo investigate the effectiveness of mechanism-based cervical sensorimotor rehabilitation on cervical muscle activation, cervical proprioception, and migraine burden.
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can peer mentors help gay men with HIV stay in care?
Disease control Not yet recruitingSexual minority men (SMM) in Jamaica face many challenges that affect their health and well-being. Although they make up a relatively small part of the population, they are much more likely to be living with HIV than the general public. Many also experience discrimination because…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Kidney transplants: a smarter way to dose Anti-Infectives?
Knowledge-focused Not yet recruitingThis study addresses the clinical problem that reliance on serum creatinine, eGFR or empirical dosing fails to accurately adjust anti-infective doses given rapid renal function shifts within the very early 0-5 days post kidney transplantation. We will systematically analyze dynam…
Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can your own blood plasma soothe severe dry eye?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the change in dry eye symptoms after the treatment with Plasma Rich in Growth Factors (PRGF) in patients with severe dry eye. The main question it aims to answer is: Are dry eye simptoms less after the treatment with PRGF? Research…
Sponsor: Gladys Lucia Silva Linares • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New hybrid heart surgery aims to spare patients from open chest incision
Disease control Recruiting nowThe MICRA-HYBRID trial is a prospective, multicenter, randomized controlled study comparing multivessel hybrid coronary revascularization (HCR) as minimally invasive arterial bypass grafting to left-sided coronary targets (LAD and LCx) plus PCI of the RCA versus conventional off-…
Sponsor: Catharina Ziekenhuis Eindhoven • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new drug ease the dryness, pain, and fatigue of Sjögren's disease?
Disease control Recruiting nowTo evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in participants with Sjögren's disease (SjD) and to determine the dose response relationship of DDY391 in participants with SjD, to support dose selection for Phase 3.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 05:00 UTC
-
Can a Dual-Targeting drug shrink Hard-to-Treat tumors?
Disease control Not yet recruitingDetailed Description: This is a multicenter, open-label, multiple-dose, first in human(FIH) Phase 1/2a trial. The Phase 1 portion uses the Bayesian optimal interval (BOIN) design to escalate doses and determine the maximum tolerated dose(MTD) and/or recommended phase 2 dose(RP2D)…
Phase 1/2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Montessori method for seniors: a new path to preserve independence?
Symptom relief Not yet recruitingThe aim of this study is to evaluate the effect of Montessori-based interventions on cognitive function and activities of daily living in older adults.
Sponsor: Gazi University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New CAR t cell therapy targets tough childhood cancers in early trial
Disease control Recruiting nowThe goal of this research study is to test if a new cell therapy (B7-H3.CD28Z.CART / B7-H3 CAR T cells) is safe and effective in treating children and young adults with solid cancers whose tumors have returned or stopped responding to standard treatments (relapsed or refractory) …
Phase 1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New heart device aims to tame persistent AFib
Disease control Recruiting nowThe purpose of this study is to assess how safe VARIPULSE catheter system is for treatment of a heart rhythm disease called persistent atrial fibrillation (PsAF) in participants who are having a catheter ablation procedure (treat heart rhythm disease). This includes isolation of …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug combo aims to tailor myeloma treatment to each patient
Disease control Not yet recruitingThe purpose of the study is to determine the best treatment approach based on the risk profile of the cancer cells and on how the disease responds to treatment. This is a randomized research study evaluating treatment for transplant-eligible participants with newly diagnosed mult…
Phase 3 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New foam could tame stubborn scalp and face rash
Disease control Not yet recruitingThis study will assess the safety and efficacy of Roflumilast foam 0.3% (ZORYVE®) versus vehicle applied once a day for 8 weeks by trial participants with seborrheic dermatitis.
Phase 3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug targets mystery itch that Won't go away
Symptom relief Recruiting nowThe purpose of this phase 3 study is to establish the efficacy, safety and tolerability of remibrutinib in adult participants with severe chronic pruritus of unknown origin (CPUO).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Sep 10, 2026 05:00 UTC
-
Antioxidant cocktail may ease motor deficits in rett syndrome — a trial investigates
Disease control Recruiting nowThis study will examine the potential efficacy and safety of Rett-T for core motor deficits of Rett syndrome, and will explore biological markers of safety and treatment response.
Phase 2 • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Wearable tech may outsmart the blood pressure cuff in preventing heart attacks
Disease control Not yet recruitingHypertension is a major risk factor for cardiovascular and cerebrovascular diseases, including stroke and myocardial infarction. Blood pressure (BP) fluctuates throughout the day in response to physical activity, emotional states, and sleep. However, hypertension diagnosis and ma…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could fixing sleep silence the ringing? a digital therapy trial aims to find out
Symptom relief Not yet recruitingThis single-center, single-blind, randomized controlled trial is designed to evaluate the efficacy of therapist-guided, internet-based cognitive behavioral therapy for insomnia (CBT-I) compared with patient education in patients with chronic subjective tinnitus and clinically sig…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC